Scholars Central

Review articlePublished 28 Apr 2023

Neurodegenerative disease gene therapy

Authors: Rajesh Khanna

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Millions of patients with neurodegenerative disorders may receive therapeutic benefit from gene therapy through a variety of ways, including direct repair of pathogenic mechanisms, neuroprotection, neurorestoration, and symptom control. Therefore, understanding the illness pathophysiology and the necessary temporal and geographic specificity of gene expression are essential for effective therapeutic outcomes. The most thorough transduction of the target structure while preventing leaking into surrounding areas or perivascular spaces is another significant difficulty. In the newest technological era of gene therapy, interventional MRI-guided convection-enhanced delivery (iMRI-CED) is the gold standard for real-time verification of precise vector administration. The availability of this cutting-edge method of neurosurgery should hasten the development of potential preclinical treatments for neurodegenerative illnesses like Parkinson's, Huntington's, and Alzheimer's.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInternational Research Journal of Basic and Clinical Studies
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Rajesh Khanna”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels